Try our Advanced Search for more refined results

2 Drug Developers Latest To Tap Market With $275M On Offer

By Zachary Zagger (March 17, 2015, 7:58 PM EDT) -- GlycoMimetics Inc. and Egalet Corp. filed for follow-on offerings Tuesday looking to raise a total of $275 million to fund further drug development becoming the latest of several drug developers that have turned to the public markets in recent weeks....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!